Jan Dörr

4.8k total citations
76 papers, 3.3k citations indexed

About

Jan Dörr is a scholar working on Pathology and Forensic Medicine, Ophthalmology and Immunology. According to data from OpenAlex, Jan Dörr has authored 76 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pathology and Forensic Medicine, 25 papers in Ophthalmology and 15 papers in Immunology. Recurrent topics in Jan Dörr's work include Multiple Sclerosis Research Studies (44 papers), Retinal and Optic Conditions (19 papers) and Ocular Diseases and Behçet’s Syndrome (10 papers). Jan Dörr is often cited by papers focused on Multiple Sclerosis Research Studies (44 papers), Retinal and Optic Conditions (19 papers) and Ocular Diseases and Behçet’s Syndrome (10 papers). Jan Dörr collaborates with scholars based in Germany, United States and Switzerland. Jan Dörr's co-authors include Friedemann Paul, Jens Wuerfel, Caspar F. Pfueller, Alexander U. Brandt, Frauke Zipp, Judith Bellmann–Strobl, Ilka Kleffner, Sven Jarius, Thoralf Niendorf and Tim Sinnecker and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Jan Dörr

72 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Dörr Germany 36 1.8k 1.0k 631 464 432 76 3.3k
Clyde Markowitz United States 25 1.6k 0.9× 918 0.9× 531 0.8× 295 0.6× 464 1.1× 59 2.7k
Judith Bellmann–Strobl Germany 38 2.4k 1.3× 623 0.6× 1.4k 2.3× 542 1.2× 728 1.7× 139 4.0k
Todd A. Hardy Australia 25 1.0k 0.6× 190 0.2× 847 1.3× 742 1.6× 357 0.8× 73 2.5k
Fritz Leutmezer Austria 29 1.2k 0.7× 110 0.1× 768 1.2× 464 1.0× 275 0.6× 126 3.1k
Darin T. Okuda United States 24 2.7k 1.5× 90 0.1× 1.1k 1.7× 484 1.0× 650 1.5× 113 3.4k
Dejan Jakimovski United States 29 2.1k 1.2× 95 0.1× 764 1.2× 472 1.0× 511 1.2× 179 3.0k
Ángela Vidal‐Jordana Spain 22 1.7k 0.9× 103 0.1× 630 1.0× 358 0.8× 473 1.1× 76 2.3k
Luca Massacesi Italy 33 1.7k 0.9× 92 0.1× 648 1.0× 730 1.6× 552 1.3× 123 3.3k
Carmen Tur Spain 31 2.7k 1.5× 119 0.1× 1.2k 2.0× 387 0.8× 751 1.7× 109 3.6k
Wolf A. Lagrèze Germany 33 257 0.1× 1.5k 1.4× 505 0.8× 1.1k 2.4× 72 0.2× 175 3.4k

Countries citing papers authored by Jan Dörr

Since Specialization
Citations

This map shows the geographic impact of Jan Dörr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Dörr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Dörr more than expected).

Fields of papers citing papers by Jan Dörr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Dörr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Dörr. The network helps show where Jan Dörr may publish in the future.

Co-authorship network of co-authors of Jan Dörr

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Dörr. A scholar is included among the top collaborators of Jan Dörr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Dörr. Jan Dörr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gómez‐Figueroa, Enrique, Priscilla Bäcker‐Koduah, Jan Dörr, et al.. (2025). Neuroprotective role of high dose Vitamin D supplementation in multiple sclerosis: Sub-analysis of the EVIDIMS trial. Multiple Sclerosis and Related Disorders. 101. 106567–106567.
2.
Wilf‐Yarkoni, Adi, et al.. (2024). Clinical Characterization and Ancillary Tests in Susac Syndrome. Neurology Neuroimmunology & Neuroinflammation. 11(3). e200209–e200209. 5 indexed citations
3.
Álvarez-González, César, Stephan Schlickeiser, Nadja Siebert, et al.. (2021). Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells. Neurotherapeutics. 18(3). 1783–1797. 8 indexed citations
4.
Rust, Rebekka, Claudia Chien, Michael Scheel, et al.. (2021). Epigallocatechin Gallate in Progressive MS. Neurology Neuroimmunology & Neuroinflammation. 8(3). 19 indexed citations
5.
Bäcker‐Koduah, Priscilla, Carmen Infante‐Duarte, Federico Ivaldi, et al.. (2020). Effect of vitamin D supplementation on N‐glycan branching and cellular immunophenotypes in MS. Annals of Clinical and Translational Neurology. 7(9). 1628–1641. 8 indexed citations
6.
Dörr, Jan, Priscilla Bäcker‐Koduah, Klaus‐Dieter Wernecke, et al.. (2020). High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(1). 2455323442–2455323442. 35 indexed citations
7.
Dörr, Jan & Friedemann Paul. (2015). The Transition From First-Line to Second-Line Therapy in Multiple Sclerosis. Current Treatment Options in Neurology. 17(6). 354–354. 44 indexed citations
8.
Brandt, Alexander U., Timm Oberwahrenbrock, Fiona Costello, et al.. (2015). RETINAL LESION EVOLUTION IN SUSAC SYNDROME. Retina. 36(2). 366–374. 19 indexed citations
9.
Jarius, Sven, Ilka Kleffner, Jan Dörr, et al.. (2014). Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study. Journal of Neuroinflammation. 11(1). 46–46. 78 indexed citations
10.
Sinnecker, Tim, Timm Oberwahrenbrock, Imke Metz, et al.. (2014). Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning – an ultrahigh-field MR pilot study. European Radiology. 25(1). 122–131. 81 indexed citations
11.
Borisow, Nadja, Friedemann Paul, Stephanie Ohlraun, et al.. (2014). Pregnancy in Multiple Sclerosis: A Questionnaire Study. PLoS ONE. 9(6). e99106–e99106. 8 indexed citations
12.
13.
Millward, Jason M., Isabell Hamann, Friedemann Paul, et al.. (2012). Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis. PLoS ONE. 7(6). e39625–e39625. 21 indexed citations
14.
Pfueller, Caspar F., Alexander U. Brandt, Markus Böck, et al.. (2011). Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis. PLoS ONE. 6(4). e18019–e18019. 67 indexed citations
15.
Dörr, Jan, Sven Jarius, Brigitte Wildemann, et al.. (2011). Susac-Syndrom. Der Nervenarzt. 82(10). 1250–1263. 12 indexed citations
16.
Böck, Markus, Alexander U. Brandt, J Kuchenbecker, et al.. (2011). Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis. British Journal of Ophthalmology. 96(1). 62–67. 57 indexed citations
17.
Böck, Markus, Alexander U. Brandt, Jan Dörr, et al.. (2010). Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clinical Neurology and Neurosurgery. 112(8). 647–652. 86 indexed citations
18.
Ahsen, Nicolas von, Niels Kruse, Brian E. Huber, et al.. (2009). ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Brain. 132(9). 2517–2530. 55 indexed citations
19.
Dörr, Jan, Helena Radbruch, Markus Böck, et al.. (2009). Encephalopathy, visual disturbance and hearing loss—recognizing the symptoms of Susac syndrome. Nature Reviews Neurology. 5(12). 683–688. 52 indexed citations
20.
Dörr, Jan, Urte Zurbuchen, Rudolf A. Deisz, et al.. (2005). Tumor-necrosis-factor-related apoptosis-inducing-ligand (TRAIL)-mediated death of neurons in living human brain tissue is inhibited by flupirtine-maleate. Journal of Neuroimmunology. 167(1-2). 204–209. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clyde Markowitz Breakdown of academic impact, for papers by Judith Bellmann–Strobl Breakdown of academic impact, for papers by Todd A. Hardy Breakdown of academic impact, for papers by Fritz Leutmezer Breakdown of academic impact, for papers by Darin T. Okuda Breakdown of academic impact, for papers by Dejan Jakimovski Breakdown of academic impact, for papers by Ángela Vidal‐Jordana Breakdown of academic impact, for papers by Luca Massacesi Breakdown of academic impact, for papers by Carmen Tur Breakdown of academic impact, for papers by Wolf A. Lagrèze
Rankless by CCL
2026